Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients - Université de Bretagne Occidentale Access content directly
Journal Articles Archives of cardiovascular diseases Year : 2018

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Domains

Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02055852

Submitted on : Monday, March 4, 2019-12:12:42 PM

Last modification on : Tuesday, October 3, 2023-10:38:03 AM

No file

Dates and versions

hal-02055852 , version 1 (04-03-2019)

Identifiers

  • HAL Id : hal-02055852 , version 1

Cite

Jean-Guillaume Dillinger, Boris Aleil, Saida Cheggour, Ygal Benhamou, Yannick Béjot, et al.. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases, 2018, 111 (2), pp.85-94. ⟨hal-02055852⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-ST-ETIENNE UNIV-BREST UNIV-PARIS7 IMRB GETBO UPEC COMUE-NORMANDIE USPC SITE-ALSACE UNIROUEN IBSAM UDL U-PICARDIE MP3CV ICL FMMS
38 View
0 Download

Share

Gmail Facebook X LinkedIn More